Partnerships

Partnerships, not profits, drive our operations

Partnerships

Partnerships, not profits, drive our operations

Collaboration is an essential part of DNDi’s model: we cannot carry out our work without the engagement of public and private partners.

Acting as a ‘conductor of a virtual orchestra,’ we leverage and give value to our partners’ specific assets, capacities, and expertise. At every phase of the R&D process – from drug discovery and pre-clinical research to clinical trials and large-scale implementation studies – DNDi manages the process, creating multiple alliances, strengthening cross-sector networks, and working in close partnership with a broad range of different actors.

Today, DNDi has forged a diverse range of alliances and research collaborations with over 200 partners in nearly 50 countries.

> 0

partners in nearly 50 countries

0 %

of all R&D partner staff are based in low- and middle-income countries

full-time-equivalent positions outside DNDi supporting our research for neglected patients for every-full-time DNDi position

A worldwide footprint anchored in endemic countries

Key statistics on our partnerships

*Figures reflect third-party institutions that contributed to a DNDi project or strategic objective in 2023 in at least one of the following ways: (i) in-kind, (ii) as a co-applicant partner to a successful funding application, or (iii) as a facilitator of local ownership of and access to new treatments.

Become a partner

Help us bring the best science to the most neglected.

Partnering for patients

Collaboration is an essential part of how we work. We have forged a diverse range of alliances and research collaborations with over 200 partners in nearly 50 countries.